新相微(688593) - 2025 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2025 reached ¥150,323,823.80, representing a 49.95% increase compared to ¥100,246,182.95 in the same period last year[2] - Net profit attributable to shareholders was ¥2,185,135.59, a significant recovery from a loss of ¥11,464,471.74 in the previous year[2] - The net profit after deducting non-recurring gains and losses increased by 67.86% to ¥1,765,995.08 from ¥1,052,066.03[2] - Net profit for Q1 2025 was ¥1,528,352.37, compared to a net loss of ¥11,679,214.58 in Q1 2024[19] - The company reported a comprehensive income of ¥1,468,974.94 for Q1 2025, compared to a loss of ¥11,604,762.41 in Q1 2024[20] - The company's net profit for Q1 2025 reached CNY 3,009,915.60, a significant recovery from a net loss of CNY 12,145,094.18 in Q1 2024[27] - Operating profit for Q1 2025 was CNY 1,119,749.30, compared to an operating loss of CNY 15,943,678.38 in the same period last year[27] - The total comprehensive income for Q1 2025 was CNY 3,009,915.60, a recovery from a total comprehensive loss of CNY 12,145,094.18 in Q1 2024[28] Cash Flow - The net cash flow from operating activities improved to ¥79,063,926.29, a turnaround from a negative cash flow of ¥41,342,723.26 in the previous year[2] - Cash inflow from operating activities in Q1 2025 totaled ¥247,018,953.33, significantly higher than ¥121,756,239.27 in Q1 2024[20] - The company's cash flow from sales of goods and services was ¥157,737,392.08 in Q1 2025, compared to ¥104,124,416.02 in Q1 2024[20] - The cash outflow from investing activities was ¥12,020,590.15, an improvement from a larger outflow of ¥30,864,102.55 in the previous period[22] - The cash inflow from financing activities was ¥34,044,678.39, a recovery from a cash outflow of ¥53,241,310.27 in the previous period[22] - The company reported a net cash flow from operating activities of CNY 51,305,836.77 in Q1 2025, compared to CNY 42,231,035.51 in Q1 2024, indicating a growth of about 21.5%[28] Research and Development - Research and development expenses totaled ¥17,810,033.72, up 59.83% from ¥11,143,156.52, accounting for 11.85% of operating revenue[3] - The company plans to continue increasing its R&D investment to enhance its capabilities across multiple product areas[6] - Research and development expenses for Q1 2025 were ¥17,810,033.72, an increase of 59.5% from ¥11,143,156.52 in Q1 2024[18] - Research and development expenses increased to CNY 16,669,735.19 in Q1 2025 from CNY 11,164,761.69 in Q1 2024, reflecting a growth of approximately 49.4%[27] Assets and Liabilities - Total assets increased by 3.23% to ¥1,844,523,432.00 from ¥1,786,890,541.17 at the end of the previous year[3] - The company's total assets as of March 31, 2025, amounted to RMB 1,844,523,432.00, an increase from RMB 1,786,890,541.17 as of December 31, 2024[14] - Current assets totaled RMB 1,461,006,730.68 as of March 31, 2025, compared to RMB 1,415,431,367.35 at the end of 2024, reflecting a growth of approximately 3.22%[14] - Total liabilities as of the reporting date were ¥280,977,178.51, up from ¥199,381,709.17 year-over-year[16] - The total liabilities rose to ¥356,242,990.09, compared to ¥279,507,080.60, indicating an increase of about 27.5%[25] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 9,768[8] - As of March 31, 2025, the company has repurchased a total of 3.331905 million shares, accounting for 0.73% of the total share capital of 45,952.9412 million shares, with a total expenditure of RMB 45,681,324.90[10] Corporate Actions - The company is currently undergoing a major asset restructuring, with its stock suspended since March 3, 2025, to facilitate the issuance of shares and cash for asset acquisition[11] - The company has been actively organizing related parties to advance the asset acquisition transaction during the suspension period[12] - The board approved a proposal for issuing shares and convertible bonds to fund the asset acquisition on March 13, 2025[12]